US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Decoy Therapeutics Inc

7.30

+0.870013.53%

Post-market: 7.300.00000.00%19:49 EDT

Volume:10.67K

Turnover:74.06K

Market Cap:3.88M

PE:-0.13

High:7.30

Open:6.43

Low:6.43

Close:6.43

52wk High:415.80

52wk Low:4.32

Shares:532.02K

Float Shares:528.43K

Volume Ratio:0.76

T/O Rate:2.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-57.1200

EPS(LYR):-129.1004

ROE:-661.73%

ROA:-54.13%

PB:1.00

PE(LYR):-0.06

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Decoy Therapeutics Inc

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

11

Office Location:

2450 Holcombe Blvd,Suite X,Houston,Texas,United States

Website:

http://www.decoytx.com

Zip Code:

77021

Phone:

Fax:

- -

Introduction:

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is headquartered in Houston, Texas.

Directors

Name

Position

Frederick E. Pierce

Chief Executive Officer and Director

William K. McVicar

Chair

Arnold C. Hanish

Director

David J. Arthur

Director

Jonathan Lieber

Director

Paul Lammers

Director

Tess Burleson

Director

Shareholders

Name

Position

Frederick E. Pierce

Chief Executive Officer and Director

Mark J. Rosenblum

Chief Financial Officer and Executive Vice President of Finance

Barbara Hibner

Chief Scientific Officer

Peter Marschel

Chief Business Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DCOY/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DCOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","market":"US","secType":"STK","nameCN":"Decoy Therapeutics Inc","latestPrice":7.3,"timestamp":1779480000000,"preClose":6.43,"halted":0,"volume":10666,"hourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.3,"latestTime":"19:49 EDT","volume":262,"amount":1954.411,"timestamp":1779493787346,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.13530326594090206,"floatShares":528425,"shares":532016,"eps":-57.119957,"marketStatus":"Market Closed","change":0.87,"latestTime":"05-22 16:00:00 EDT","open":6.43,"high":7.3,"low":6.43,"amount":74055.979212,"amplitude":0.135303,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-57.119957,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"listingDate":1422507600000,"exchange":"NASDAQ","adjPreClose":6.43,"preHourTrading":{"tag":"盘前","latestPrice":5.94,"preClose":6.26,"latestTime":"08:40 EDT","volume":13,"amount":78.9799998,"timestamp":1779453600413,"change":-0.32,"changeRate":-0.051118,"amplitude":0.070288},"postHourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.3,"latestTime":"19:49 EDT","volume":262,"amount":1954.411,"timestamp":1779493787346,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7601749322990407},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","floatShares":528425,"roa":"-54.13%","roe":"-661.73%","lyrEps":-129.100415,"volumeRatio":0.7601749322990407,"shares":532016,"dividePrice":0,"high":7.3,"amplitude":0.135303,"preClose":6.43,"low":6.43,"week52Low":4.3201,"pbRate":"1.00","week52High":415.8,"institutionHeld":0,"latestPrice":7.3,"eps":-57.119957,"divideRate":0,"volume":10666,"delay":0,"ttmEps":-57.119957,"open":6.43,"prevYearClose":7.7856,"prevWeekClose":4.41,"prevMonthClose":6.05,"prevQuarterClose":6.5306,"fiveDayClose":4.41,"twentyDayClose":5.425,"sixtyDayClose":8.196},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DCOY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-08","symbol":"DCOY","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"post","actualEps":-4.18},{"market":"US","date":"2026-03-31","symbol":"DCOY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2026-03-09","symbol":"DCOY","defaultRemindTime":1773063000000,"type":"split","dateTimestamp":1773028800000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DCOY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DCOY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DCOY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DCOY","date":"2026-05-21","current":-0.127801,"percent":0.923913,"low":-1.594527,"twenty":-0.964472,"median":-0.803641,"eighty":-0.247404,"high":-0.179995,"avg":-0.668561,"sd":0.349379,"marketCap":2957742},"quantilePoints":[{"date":"2026-01-09","current":-0.982229,"twenty":-1.053663,"median":-1.026876,"eighty":-1.000088,"marketCap":4915816},{"date":"2026-01-16","current":-1.227403,"twenty":-1.203881,"median":-1.071522,"eighty":-1.040856,"marketCap":6142855},{"date":"2026-01-23","current":-0.957354,"twenty":-1.160688,"median":-1.045754,"eighty":-0.982229,"marketCap":4791324},{"date":"2026-01-30","current":-1.05749,"twenty":-1.109791,"median":-1.050666,"eighty":-0.994985,"marketCap":5292482},{"date":"2026-02-06","current":-0.790885,"twenty":-1.101882,"median":-1.039631,"eighty":-0.91832,"marketCap":3958189},{"date":"2026-02-13","current":-0.956844,"twenty":-1.071522,"median":-0.994921,"eighty":-0.926101,"marketCap":4788771},{"date":"2026-02-20","current":-1.018456,"twenty":-1.060296,"median":-0.989117,"eighty":-0.939163,"marketCap":5097126},{"date":"2026-02-27","current":-0.871249,"twenty":-1.05596,"median":-0.982229,"eighty":-0.908242,"marketCap":4360392},{"date":"2026-03-06","current":-0.74305,"twenty":-1.047719,"median":-0.957099,"eighty":-0.869974,"marketCap":3718783},{"date":"2026-03-13","current":-0.796199,"twenty":-1.041162,"median":-0.954292,"eighty":-0.863596,"marketCap":3984784},{"date":"2026-03-20","current":-0.84935,"twenty":-1.039708,"median":-0.934265,"eighty":-0.844716,"marketCap":4250791},{"date":"2026-03-27","current":-0.746769,"twenty":-1.027385,"median":-0.915268,"eighty":-0.830428,"marketCap":3737398},{"date":"2026-04-02","current":-0.671826,"twenty":-1.020803,"median":-0.90314,"eighty":-0.800664,"marketCap":3362328},{"date":"2026-04-10","current":-0.254968,"twenty":-1.004373,"median":-0.87465,"eighty":-0.787058,"marketCap":3191808},{"date":"2026-04-17","current":-0.249443,"twenty":-0.994908,"median":-0.869974,"eighty":-0.73327,"marketCap":3122652},{"date":"2026-04-24","current":-0.230321,"twenty":-0.987969,"median":-0.855197,"eighty":-0.507377,"marketCap":2883266},{"date":"2026-05-01","current":-0.257092,"twenty":-0.982688,"median":-0.845098,"eighty":-0.256242,"marketCap":3218406},{"date":"2026-05-08","current":-0.243919,"twenty":-0.982229,"median":-0.84006,"eighty":-0.250421,"marketCap":3053496},{"date":"2026-05-15","current":-0.184485,"twenty":-0.974422,"median":-0.810018,"eighty":-0.248296,"marketCap":2404495},{"date":"2026-05-21","current":-0.226933,"twenty":-0.964472,"median":-0.803641,"eighty":-0.247404,"marketCap":2957742}],"updateTime":1779511999417},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":330031056,"employeeNum":11,"address":"2450 Holcombe Blvd,Suite X,Houston,Texas,United States","zipCode":"77021","officePhone":"713 913 5608","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.decoytx.com","stockEarnings":[{"period":"1week","weight":0.6553},{"period":"1month","weight":0.3494},{"period":"3month","weight":-0.1804},{"period":"6month","weight":-0.3008},{"period":"1year","weight":-0.9478},{"period":"ytd","weight":-0.0624}],"compareEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":0.0484},{"period":"3month","weight":0.0815},{"period":"6month","weight":0.1314},{"period":"1year","weight":0.2788},{"period":"ytd","weight":0.0934}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is headquartered in Houston, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.032258},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.05363},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.015981},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.073653},{"month":5,"riseRate":0.583333,"avgChangeRate":0.012591},{"month":6,"riseRate":0.545455,"avgChangeRate":-0.047064},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.136217},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.111993},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.12638},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.128321},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.062226},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.07199}],"exchange":"NASDAQ","name":"Decoy Therapeutics Inc","nameEN":"Decoy Therapeutics Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DCOY\",market:\"US\",,,undefined,":{"directors":[{"name":"Frederick E. Pierce","position":"Chief Executive Officer and Director"},{"name":"William K. McVicar","position":"Chair"},{"name":"Arnold C. Hanish","position":"Director"},{"name":"David J. Arthur","position":"Director"},{"name":"Jonathan Lieber","position":"Director"},{"name":"Paul Lammers","position":"Director"},{"name":"Tess Burleson","position":"Director"}],"executives":[{"name":"Frederick E. Pierce","position":"Chief Executive Officer and Director"},{"name":"Mark J. Rosenblum","position":"Chief Financial Officer and Executive Vice President of Finance"},{"name":"Barbara Hibner","position":"Chief Scientific Officer"},{"name":"Peter Marschel","position":"Chief Business Officer"}]}}}